OUR TEAM
Gentronix Ltd. comprises a team of people who are passionate about the science of toxicology. Combined, we have decades of experience within predictive toxicology space and the SME environment and together we are committed to delivering the highest quality science, in an effective and efficient manner.
A WEALTH OF EXPERIENCE
Matt has been with the business since 2006.
Nick is one of the company’s originating scientists, initially as a PhD student in the founding lab.
Laura joined Gentronix in 2020 as an Operations Director to work towards delivering ambitious growth plans as part of the senior leadership team.
Darryl White
Chief Financial Officer
Darryl is Gentronix’s Chief Financial Officer, equipped with a strong financial background and a wealth of experience in the industry.
LUCINDA LILLFORD
Head of Genetic Toxicology
Lucinda is the Head of Genetic Toxicology at Gentronix, leading our genetic toxicology lab teams with over 20 years of experience in regulatory genotox.
Elias joined Gentronix in 2020 as a Business Development Manager, having previously worked in sales development within a genomic stabilisation devices company in Canada.
Simrit joined the Gentronix Business Development team in 2024, with a Masters in Toxicology and over 8 years of experience in driving business growth for GLP CROs and chemical consultancies.
Paige joined Gentronix as a Business Development Manager in 2024.
Lydia joined the company in 2023 after graduating from the University of Manchester in Biology with Science and Society.
OUR VALUES
OUR VALUES
Our business origins are in the delivery of innovative screening products for toxicological hazard; challenging the established approach with scientific rigour. Building on our experiences of developing market leading predictive toxicology assays, we have extended our expertise to the regulatory tests for genetic toxicology and recently skin sensitisation.
We make a commitment to our clients to perform toxicology studies of the highest scientific quality; not merely to produce data, but to deliver the most appropriate data endpoints, using the right assay tools, guided by scientific engagement and experience. Furthermore, we are committed to helping our clients understand and interpret their results, supporting navigation of regulatory landscapes and management of adverse toxicology findings.
This is guided by our core values, which we apply to all the studies we perform:
Our business origins are in the delivery of innovative screening products for toxicological hazard; challenging the established approach with scientific rigour. Building on our experiences of developing market leading predictive toxicology assays, we have extended our expertise to the regulatory tests for genetic toxicology and recently skin sensitisation.
We make a commitment to our clients to perform toxicology studies of the highest scientific quality; not merely to produce data, but to deliver the most appropriate data endpoints, using the right assay tools, guided by scientific engagement and experience. Furthermore, we are committed to helping our clients understand and interpret their results, supporting navigation of regulatory landscapes and management of adverse toxicology findings.
This is guided by our core values, which we apply to all the studies we perform: